₹5,411.00-29.55 (-0.54%)
09:49 AM, 13-Dec-2024₹5,408.25-27.00 (-0.50%)
09:34 AM, 13-Dec-2024BSE : 539523
NSE : ALKEM
Sector : Health care
ISIN Code : INE540L01014
Last Updated: 13-Dec-2024 | 09:49 AM IST
Market Cap (₹ Cr) | 64,689 |
Traded Value (₹ Cr) | 0.11 |
Volume (Shares) | 201 |
Face Value (₹) | 2 |
52-Week High (₹) | 6,440.00 |
52-Week High Date | 17-Sep-2024 |
52-Week Low (₹) | 4,409.90 |
52-Week Low Date | 04-Jun-2024 |
All Time High (₹) | 6,440.00 |
All Time High Date | 17-Sep-2024 |
All Time Low (₹) | 1,175.00 |
All Time Low Date | 02-May-2016 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 64,656 |
EPS - TTM (₹) [C] | 181.86 |
P/E Ratio (X) [C] | 29.74 |
Face Value (₹) | 2 |
Latest Dividend (%) | 250.00 |
Latest Dividend Date | 09-Aug-2024 |
Dividend Yield (%) | 0.74 |
Book Value Share (₹) [C] | 961.22 |
P/B Ratio (₹) [C] | 5.63 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
ICICI Pru Multi-Asset Fund (G) | 580.73 | 10,29,222 | 1.14 |
ICICI Pru Multi-Asset Fund - Direct (G) | 580.73 | 10,29,222 | 1.14 |
AXIS Midcap Fund (G) | 502.81 | 8,91,122 | 1.66 |
AXIS Midcap Fund (IDCW) | 502.81 | 8,91,122 | 1.66 |
AXIS Midcap Fund - Direct (G) | 502.81 | 8,91,122 | 1.66 |
AXIS Midcap Fund - Direct (IDCW) | 502.81 | 8,91,122 | 1.66 |
ICICI Pru Large & Mid Cap Fund - (G) | 497.81 | 8,82,263 | 2.81 |
ICICI Pru Large & Mid Cap Fund - (IDCW) | 497.81 | 8,82,263 | 2.81 |
ICICI Pru Large & Mid Cap Fund - Direct (G) | 497.81 | 8,82,263 | 2.81 |
ICICI Pru Large & Mid Cap Fund - Direct (IDCW) | 497.81 | 8,82,263 | 2.81 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
14-Nov-2024 | Motilal Oswal | Neutral | 5,720 | |
30-May-2024 | Motilal Oswal | Neutral | 5,390 |
Today's Low/High (₹) | 5,407.95 5,447.00 |
Week Low/High (₹) | 5,405.50 5,700.00 |
Month Low/High (₹) | 5,361.05 5,751.00 |
Year Low/High (₹) | 4,407.05 6,440.00 |
All time Low/High (₹) | 1,175.00 6,440.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -1.77% | -1.76% | -1.24 | -1.16% |
1 Month | -2.97% | -2.92% | 3.87 | 3.53% |
3 Month | -15.00% | -15.05% | -2.65 | -3.80% |
6 Month | 6.18% | 6.26% | 5.06 | 4.24% |
1 Year | 10.62% | 10.70% | 15.97 | 16.56% |
3 Year | 57.16% | 57.22% | 38.46 | 40.44% |
Executive Chairman : Basudeo N Singh
Managing Director : SANDEEP SINGH
Executive Director : Mritunjay Kumar Singh
Non-Exec. & Independent Dir. : A K Purwar
Non-Exec. & Independent Dir. : SANGEETA KAPILJIT SINGH
Non-Exec. & Independent Dir. : SUDHA RAVI
Company Sec. & Compli. Officer : Manish Narang
Non-Exec. & Independent Dir. : Narendra Aneja
Executive Director : SARVESH SINGH
Executive Director : Madhurima Singh
Independent Director : Sujjain Talwar
Executive Director : Srinivas Singh
Registered Office: Alkem House SenapatiBapat Marg, Lower Parel,Mumbai,Maharashtra-400013 Ph: 91-22-39829999
1. What's the Alkem Laboratories Ltd share price today?
Alkem Laboratories Ltd share price was Rs 5,411.00 at 09:49 AM IST on 13th Dec 2024. Alkem Laboratories Ltd share price was down by 0.54% from the previous closing price of Rs 5,440.55. Alkem Laboratories Ltd share price trend:
2. How can I quickly analyse the performance of the Alkem Laboratories Ltd stock?
The performance of the Alkem Laboratories Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Alkem Laboratories Ltd?
Alkem Laboratories Ltd has a market capitalisation of Rs 64,689 crore.
4. What is Alkem Laboratories Ltd's 52-week high/low share price?
The Alkem Laboratories Ltd’s 52-week high share price is Rs 6,440.00 and 52-week low share price is Rs 4,409.90.
5. Is the Alkem Laboratories Ltd profitable?
On a consolidated basis, Alkem Laboratories Ltd reported a profit of Rs 697.58 crore on a total income of Rs 2,992.16 crore for the quarter ended 2024. For the year ended Sep 2024, Alkem Laboratories Ltd had posted a profit of Rs 701.96 crore on a total income of Rs 3,549.15 crore.
6. Which are Alkem Laboratories Ltd’s peers in the Health care sector?
Alkem Laboratories Ltd’s top 5 peers in the Health care sector are Zydus Lifesci., Lupin, Aurobindo Pharma, Alkem Lab, Abbott India, Biocon, Glenmark Pharma..
7. Who owns how much in Alkem Laboratories Ltd?
Key changes to the Alkem Laboratories Ltd shareholding are as follows: